Suspect-and-test checklist
Gaucher disease
Autosomal recessive lysosomal disease. An enzyme blood test confirms it; a bone marrow biopsy is not routinely needed for diagnosis.
ICD-10-CME75.22Trial Friend for Clinicians
1Red flags present
Blood and spleen
Liver and gut
Bones and joints
Types 2 and 3, ancestry and family
2Already labeled as
3Family to test
4Testing, in the order the sources describe
- When to test earlyPer the 2011 consensus, a prudent first-line test in Ashkenazi Jewish patients with splenomegaly and cytopenia; should become mandatory before splenectomy for unexplained splenomegaly.Result
- Chitotriosidase, CCL18 or lyso-Gb1IWGGD first-line options. Normal chitotriosidase alone: exclude the CHIT1 duplication. Enzyme assay still needed.Result
- Dried blood spot glucocerebrosidaseFirst-line screen only. Low results always need leukocyte or fibroblast confirmation.Result
- Leukocyte glucocerebrosidase activityActivity of 0% to 15% of normal establishes the diagnosis. Fibroblasts after transfusion.Result
- GBA1 sequencingConfirms and names variants; GBAP1 pseudogene complicates panels. One or no variant: deletion/duplication.Result
- Bone marrow only for another questionNot routinely needed for diagnosis; aspirates miss cases and pseudo-Gaucher cells mislead.Result
- CYP2D6 genotype before CerdelgaFDA-cleared test; indication covers adults with type 1 disease who are extensive, intermediate or poor metabolizers.Result
5Results the sources say do not rule it out
- No splenomegaly. It can be mild or absent, especially in older N370S homozygotes.
- A normal dried blood spot result in a patient with suggestive symptoms.
- A negative common-variant GBA1 panel. Full sequencing is recommended if suspicion is strong.
- A marrow aspirate without Gaucher cells. False negatives are common on aspirate.
6Specialists the sources name
Diagnosis code: E75.22 Gaucher diseaseCodes patients often carry before diagnosis are listed in the online guide.
Full guide and sourcesEvery point here is sourced in the online guide, which also has a patient note to print.
Trial Friend, trialfriend.com/for-clinicians. Key sources: GeneReviews (2023); 2011 consensus algorithms; GED-C Delphi consensus (2019); GED-C scoring system validation (2020); GED-C real-world study (2024); IWGGD laboratory guidelines (2022); all 18 with links in the online guide. Checked November 9, 2026. A reference checklist for licensed clinicians that summarizes published sources. It is not a diagnostic tool, a score or a protocol, and it does not replace clinical judgment, local practice or the prescribing information. Not coding advice. Trial Friend never receives anything written or typed on this sheet.